Literature DB >> 25967273

Recovery from severe H7N9 disease is associated with diverse response mechanisms dominated by CD8⁺ T cells.

Zhongfang Wang1, Yanmin Wan2, Chenli Qiu2, Sergio Quiñones-Parra3, Zhaoqin Zhu2, Liyen Loh3, Di Tian2, Yanqin Ren2, Yunwen Hu2, Xiaoyan Zhang2, Paul G Thomas4, Michael Inouye5, Peter C Doherty6, Katherine Kedzierska3, Jianqing Xu2.   

Abstract

The avian origin A/H7N9 influenza virus causes high admission rates (>99%) and mortality (>30%), with ultimately favourable outcomes ranging from rapid recovery to prolonged hospitalization. Using a multicolour assay for monitoring adaptive and innate immunity, here we dissect the kinetic emergence of different effector mechanisms across the spectrum of H7N9 disease and recovery. We find that a diversity of response mechanisms contribute to resolution and survival. Patients discharged within 2-3 weeks have early prominent H7N9-specific CD8(+) T-cell responses, while individuals with prolonged hospital stays have late recruitment of CD8(+)/CD4(+) T cells and antibodies simultaneously (recovery by week 4), augmented even later by prominent NK cell responses (recovery >30 days). In contrast, those who succumbed have minimal influenza-specific immunity and little evidence of T-cell activation. Our study illustrates the importance of robust CD8(+) T-cell memory for protection against severe influenza disease caused by newly emerging influenza A viruses.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25967273      PMCID: PMC4479016          DOI: 10.1038/ncomms7833

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  36 in total

1.  Measuring the diaspora for virus-specific CD8+ T cells.

Authors:  D R Marshall; S J Turner; G T Belz; S Wingo; S Andreansky; M Y Sangster; J M Riberdy; T Liu; M Tan; P C Doherty
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-08       Impact factor: 11.205

2.  Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans.

Authors:  Tom M Wilkinson; Chris K F Li; Cecilia S C Chui; Arthur K Y Huang; Molly Perkins; Julia C Liebner; Rob Lambkin-Williams; Anthony Gilbert; John Oxford; Ben Nicholas; Karl J Staples; Tao Dong; Daniel C Douek; Andrew J McMichael; Xiao-Ning Xu
Journal:  Nat Med       Date:  2012-01-29       Impact factor: 53.440

3.  Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature.

Authors:  Suzanne L Epstein
Journal:  J Infect Dis       Date:  2005-11-21       Impact factor: 5.226

Review 4.  Similarities and differences in CD4+ and CD8+ effector and memory T cell generation.

Authors:  Robert A Seder; Rafi Ahmed
Journal:  Nat Immunol       Date:  2003-09       Impact factor: 25.606

5.  The magnitude and specificity of influenza A virus-specific cytotoxic T-lymphocyte responses in humans is related to HLA-A and -B phenotype.

Authors:  A C M Boon; G de Mutsert; Y M F Graus; R A M Fouchier; K Sintnicolaas; A D M E Osterhaus; G F Rimmelzwaan
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

6.  Quantifying the early immune response and adaptive immune response kinetics in mice infected with influenza A virus.

Authors:  Hongyu Miao; Joseph A Hollenbaugh; Martin S Zand; Jeanne Holden-Wiltse; Tim R Mosmann; Alan S Perelson; Hulin Wu; David J Topham
Journal:  J Virol       Date:  2010-04-21       Impact factor: 5.103

7.  Kinetics of serological responses in influenza A(H7N9)-infected patients correlate with clinical outcome in China, 2013.

Authors:  A Zhang; Y Huang; D Tian; E H Lau; Y Wan; X Liu; Y Dong; Z Song; X Zhang; J Zhang; M Bao; M Zhou; S Yuan; J Sun; Z Zhu; Y Hu; L Chen; C Y Leung; J T Wu; Z Zhang; X Zhang; J S Peiris; J Xu
Journal:  Euro Surveill       Date:  2013-12-12

8.  Cross-protective immunity against influenza pH1N1 2009 viruses induced by seasonal influenza A (H3N2) virus is mediated by virus-specific T-cells.

Authors:  Marine L B Hillaire; Stella E van Trierum; Joost H C M Kreijtz; Rogier Bodewes; Martina M Geelhoed-Mieras; Nella J Nieuwkoop; Ron A M Fouchier; Thijs Kuiken; Albert D M E Osterhaus; Guus F Rimmelzwaan
Journal:  J Gen Virol       Date:  2011-06-08       Impact factor: 3.891

9.  High levels of virus-specific CD4+ T cells predict severe pandemic influenza A virus infection.

Authors:  Yan Zhao; Yong-Hong Zhang; Laura Denney; Duncan Young; Tim J Powell; Yan-Chun Peng; Ning Li; Hui-Ping Yan; Da-Yan Wang; Yue-Long Shu; Yvonne Kendrick; Andrew J McMichael; Ling-Pei Ho; Tao Dong
Journal:  Am J Respir Crit Care Med       Date:  2012-10-18       Impact factor: 21.405

10.  Safe pseudovirus-based assay for neutralization antibodies against influenza A(H7N9) virus.

Authors:  Chao Qiu; Yang Huang; Anli Zhang; Di Tian; Yanmin Wan; Xiaoling Zhang; Wanju Zhang; Zhiyong Zhang; Zhenghong Yuan; Yunwen Hu; Xiaoyan Zhang; Jianqing Xu
Journal:  Emerg Infect Dis       Date:  2013-10       Impact factor: 6.883

View more
  106 in total

1.  Positive Selection in CD8+ T-Cell Epitopes of Influenza Virus Nucleoprotein Revealed by a Comparative Analysis of Human and Swine Viral Lineages.

Authors:  Heather M Machkovech; Trevor Bedford; Marc A Suchard; Jesse D Bloom
Journal:  J Virol       Date:  2015-08-26       Impact factor: 5.103

2.  Characterization of antibody and memory T-cell response in H7N9 survivors: a cross-sectional analysis.

Authors:  M-J Ma; X-X Wang; M-N Wu; X-J Wang; C-J Bao; H-J Zhang; Y Yang; K Xu; G-L Wang; M Zhao; W Cheng; W-J Chen; W-H Zhang; L-Q Fang; W J Liu; E-F Chen; W-C Cao
Journal:  Clin Microbiol Infect       Date:  2019-06-20       Impact factor: 8.067

3.  H1N1pdm09 Influenza Virus and Its Descendants Lack Extra-epitopic Amino Acid Residues Associated With Reduced Recognition by M158-66-Specific CD8+ T Cells.

Authors:  Carolien E van de Sandt; Kyung A Sagong; Mark R Pronk; Theo M Bestebroer; Monique I Spronken; Marion P G Koopmans; Ron A M Fouchier; Guus F Rimmelzwaan
Journal:  J Infect Dis       Date:  2018-07-13       Impact factor: 5.226

4.  Influenza-specific lung-resident memory T cells are proliferative and polyfunctional and maintain diverse TCR profiles.

Authors:  Angela Pizzolla; Thi Ho Nguyen; Sneha Sant; Jade Jaffar; Tom Loudovaris; Stuart I Mannering; Paul G Thomas; Glen P Westall; Katherine Kedzierska; Linda M Wakim
Journal:  J Clin Invest       Date:  2018-01-08       Impact factor: 14.808

5.  Impaired Cellular Immune Responses During the First Week of Severe Acute Influenza Infection.

Authors:  Jackson S Turner; Tingting Lei; Aaron J Schmitz; Aaron Day; José Alberto Choreño-Parra; Luis Jiménez-Alvarez; Alfredo Cruz-Lagunas; Stacey L House; Joaquín Zúñiga; Ali H Ellebedy; Philip A Mudd
Journal:  J Infect Dis       Date:  2020-09-01       Impact factor: 5.226

Review 6.  Role of Aging and the Immune Response to Respiratory Viral Infections: Potential Implications for COVID-19.

Authors:  Judy Chen; William J Kelley; Daniel R Goldstein
Journal:  J Immunol       Date:  2020-06-03       Impact factor: 5.422

Review 7.  Inactivated influenza virus vaccines: the future of TIV and QIV.

Authors:  Michael Schotsaert; Adolfo García-Sastre
Journal:  Curr Opin Virol       Date:  2017-05-12       Impact factor: 7.090

8.  Variation at Extra-epitopic Amino Acid Residues Influences Suppression of Influenza Virus Replication by M158-66 Epitope-Specific CD8+ T Lymphocytes.

Authors:  Carolien E van de Sandt; Mark R Pronk; Carel A van Baalen; Ron A M Fouchier; Guus F Rimmelzwaan
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

9.  Antigenic Restimulation of Virus-Specific Memory CD8+ T Cells Requires Days of Lytic Protein Accumulation for Maximal Cytotoxic Capacity.

Authors:  Stephen A Migueles; Daniel C Rogan; Noah V Gavil; Elizabeth P Kelly; Sushila A Toulmin; Lawrence T Wang; Justin Lack; Addison J Ward; Patrick F Pryal; Amanda K Ludwig; Renata G Medina; Benjamin J Apple; Christina N Toumanios; April L Poole; Catherine A Rehm; Sara E Jones; C Jason Liang; Mark Connors
Journal:  J Virol       Date:  2020-11-09       Impact factor: 5.103

Review 10.  Development of a Universal Influenza Vaccine.

Authors:  Leonardo D Estrada; Stacey Schultz-Cherry
Journal:  J Immunol       Date:  2019-01-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.